133 related articles for article (PubMed ID: 9802336)
1. A comparison of the enantioselectivities of human deoxycytidine kinase and human cytidine deaminase.
Shafiee M; Griffon JF; Gosselin G; Cambi A; Vincenzetti S; Vita A; Eriksson S; Imbach JL; Maury G
Biochem Pharmacol; 1998 Nov; 56(9):1237-42. PubMed ID: 9802336
[TBL] [Abstract][Full Text] [Related]
2. Lack of enantiospecificity of human 2'-deoxycytidine kinase: relevance for the activation of beta-L-deoxycytidine analogs as antineoplastic and antiviral agents.
Verri A; Focher F; Priori G; Gosselin G; Imbach JL; Capobianco M; Garbesi A; Spadari S
Mol Pharmacol; 1997 Jan; 51(1):132-8. PubMed ID: 9016355
[TBL] [Abstract][Full Text] [Related]
3. Low enantioselectivities of human deoxycytidine kinase and human deoxyguanosine kinase with respect to 2'-deoxyadenosine, 2'-deoxyguanosine and their analogs.
Gaubert G; Gosselin G; Boudou V; Imbach JL; Eriksson S; Maury G
Biochimie; 1999 Nov; 81(11):1041-7. PubMed ID: 10575360
[TBL] [Abstract][Full Text] [Related]
4. Stratification of nucleoside analog chemotherapy using 1-(2'-deoxy-2'-18F-fluoro-β-D-arabinofuranosyl)cytosine and 1-(2'-deoxy-2'-18F-fluoro-β-L-arabinofuranosyl)-5-methylcytosine PET.
Lee JT; Campbell DO; Satyamurthy N; Czernin J; Radu CG
J Nucl Med; 2012 Feb; 53(2):275-80. PubMed ID: 22302964
[TBL] [Abstract][Full Text] [Related]
5. Unnatural enantiomers of 5-azacytidine analogues: syntheses and enzymatic properties.
Gaubert G; Mathé C; Imbach J; Eriksson S; Vincenzetti S; Salvatori D; Vita A; Maury G
Eur J Med Chem; 2000 Nov; 35(11):1011-9. PubMed ID: 11137229
[TBL] [Abstract][Full Text] [Related]
6. Unnatural enantiomers of 5-azacytidine analogues: syntheses and enzymatic properties.
Gaubert G; Gosselin G; Eriksson S; Vita A; Maury G
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):837-40. PubMed ID: 11563127
[TBL] [Abstract][Full Text] [Related]
7. Kinetic studies on 2',2'-difluorodeoxycytidine (Gemcitabine) with purified human deoxycytidine kinase and cytidine deaminase.
Bouffard DY; Laliberté J; Momparler RL
Biochem Pharmacol; 1993 May; 45(9):1857-61. PubMed ID: 8494545
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel alters the expression and specific activity of deoxycytidine kinase and cytidine deaminase in non-small cell lung cancer cell lines.
Shord SS; Patel SR
J Exp Clin Cancer Res; 2009 Jun; 28(1):76. PubMed ID: 19500405
[TBL] [Abstract][Full Text] [Related]
9. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
Katahira R; Ashihara H
Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
[TBL] [Abstract][Full Text] [Related]
10. Chiral discrimination of 2'-deoxy-L-cytidine and L-nucleotides by mouse deoxycytidine kinase: low stereospecificities for substrates and effectors.
Tomikawa A; Kohgo S; Ikezawa H; Iwanami N; Shudo K; Kawaguchi T; Saneyoshi M; Yamaguchi T
Biochem Biophys Res Commun; 1997 Oct; 239(1):329-33. PubMed ID: 9345319
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomics of gemcitabine metabolism: functional analysis of genetic variants in cytidine deaminase and deoxycytidine kinase.
Baker JA; Wickremsinhe ER; Li CH; Oluyedun OA; Dantzig AH; Hall SD; Qian YW; Ring BJ; Wrighton SA; Guo Y
Drug Metab Dispos; 2013 Mar; 41(3):541-5. PubMed ID: 23230131
[TBL] [Abstract][Full Text] [Related]
12. Impact of cytidine deaminase activity on intrinsic resistance to cytarabine in carcinoma cells.
Ohta T; Hori H; Ogawa M; Miyahara M; Kawasaki H; Taniguchi N; Komada Y
Oncol Rep; 2004 Nov; 12(5):1115-20. PubMed ID: 15492802
[TBL] [Abstract][Full Text] [Related]
13. Stereoisomeric selectivity of human deoxyribonucleoside kinases.
Wang J; Choudhury D; Chattopadhyaya J; Eriksson S
Biochemistry; 1999 Dec; 38(51):16993-9. PubMed ID: 10606535
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity.
Kroep JR; Loves WJ; van der Wilt CL; Alvarez E; Talianidis I; Boven E; Braakhuis BJ; van Groeningen CJ; Pinedo HM; Peters GJ
Mol Cancer Ther; 2002 Apr; 1(6):371-6. PubMed ID: 12477049
[TBL] [Abstract][Full Text] [Related]
15. Enzymatic properties of the unnatural beta-L-enantiomers of 2',3'-dideoxyadenosine and 2',3'-didehydro-2',3'-dideoxyadenosine.
Pélicano H; Pierra C; Eriksson S; Gosselin G; Imbach JL; Maury G
J Med Chem; 1997 Nov; 40(24):3969-73. PubMed ID: 9397178
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the effect of phosphorylated metabolites of anti-human immunodeficiency virus and anti-hepatitis B virus pyrimidine analogs on the behavior of human deoxycytidylate deaminase.
Liou JY; Krishnan P; Hsieh CC; Dutschman GE; Cheng YC
Mol Pharmacol; 2003 Jan; 63(1):105-10. PubMed ID: 12488542
[TBL] [Abstract][Full Text] [Related]
17. Affinity of the antiviral enantiomers of oxathiolane cytosine nucleosides for human 2'-deoxycytidine kinase.
Shewach DS; Liotta DC; Schinazi RF
Biochem Pharmacol; 1993 Apr; 45(7):1540-3. PubMed ID: 8385948
[TBL] [Abstract][Full Text] [Related]
18. Substrate/inhibitor specificities of human deoxycytidine kinase (dCK) and thymidine kinases (TK1 and TK2).
Kierdaszuk B; Krawiec K; Kazimierczuk Z; Jacobsson U; Johansson NG; Munch-Petersen B; Eriksson S; Shugar D
Adv Exp Med Biol; 1998; 431():623-7. PubMed ID: 9598140
[TBL] [Abstract][Full Text] [Related]
19. Docking simulation with a purine nucleoside specific homology model of deoxycytidine kinase, a target enzyme for anticancer and antiviral therapy.
Johnsamuel J; Eriksson S; Oliveira M; Tjarks W
Bioorg Med Chem; 2005 Jul; 13(13):4160-7. PubMed ID: 15876539
[TBL] [Abstract][Full Text] [Related]
20. Differences in kinetic properties of pure recombinant human and mouse deoxycytidine kinase.
Johansson M; Karlsson A
Biochem Pharmacol; 1995 Jul; 50(2):163-8. PubMed ID: 7632159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
